Category Archives: Sales

Pharm Exec's 11th Annual Industry Audit: A Snapshot

By Guest Blogger | Published: September 18, 2012

Compiled by Bill Trombetta, Professor of Pharmaceutical & Healthcare Marketing at St. Joseph University, Pharm Exec’s 11th Annual Industry aims to provide a snapshot of how well companies are doing in advancing shareholder value. Pharm Exec’s 2012 Industry Audit relies on 2011 data to compare performance against 2010. As in years past, we use eight metrics [...]

Also posted in Guest Blog, Strategy | Tagged gross margin, industry audit, sales revue, shareholder value, shares | Leave a comment

Customer Engagement: Can Technology Help Find That Sweet Spot?

By William Looney | Published: September 17, 2012

In the rush toward customer engagement, can technology find the sweet spot? Cegedim Relationship Management held its annual conference on trends in the life sciences industry last week, with two days of speakers and workshops focused on the interrelated themes of Transformation and Innovation. The central question: if the business of pharma is changing at warp [...]

Also posted in Events, Patient Communication, Technology, healthcare | Tagged Cegedim Relationship Management, e-detailing, patient access, Sales, Technology | 2 Comments

Advancing Pharma's Social Media Listening Analytics

By Ben Comer | Published: September 6, 2012

Big Pharma’s tin ear for social, user-generated content online is softening despite regulatory anxiety. In the quest to better understand what patients and doctors need, pharma – thanks in part to a bevy of third-party service providers – is beginning to recognize and incorporate insights from social media into their development and commercialization programs, according [...]

Also posted in Advertising, Agency Insight, E-Media, Marketing, Regulatory, Strategy, Technology, social media | Tagged Agency, Marketing, Professional Marketing, social media | 5 Comments

Forest Labs Hit with Bad Ad Tattle

By Ben Comer | Published: August 7, 2012

Forest Labs has had a tough time with regulators over the last two years. The company’s sales reps can’t seem to stop breaking the law. The latest offense, which generated an Untitled Letter from the Office of Prescription Drug Promotion (OPDP), was brought to light through OPDP’s Bad Ad program, which encourages physicians to report on [...]

Also posted in Corporate Responsibility, FDA, Legal, Marketing, Regulatory, compliance | Tagged Bad Ad, compliance, off-label, OIG, OPDP, Regulatory, Sales Reps, Untitled Letter | Leave a comment

Bristol-Myers Squibb's Summertime Blues

By Ben Comer | Published: August 7, 2012

The sun was shining, savory scents were floating out from the grill, the lemonade was mixed and the table was set. But then dark clouds blew in and settled overhead. Bristol-Myers Squibb’s (BMS) picnic got rained out this summer. One element of the rain out was forecasted long ago; Plavix, the multibillion dollar [...]

Also posted in Advertising, Biotech, Deals, FDA, Legal, Marketing, R&D, Regulatory, Safety, Strategy, compliance, pricing | Tagged Bristol-Meyers Squibb, FDA, Office of Prescription Drug Promotion, OPDP, Regulatory, Untitled Letter | Leave a comment